메뉴 건너뛰기




Volumn 18, Issue 1, 2013, Pages 13-18

Effects of statin monotherapy versus statin plus ezetimibe combination on serum uric acid levels

Author keywords

ezetimibe; renal function; rosuvastatin; simvastatin; uric acid

Indexed keywords

CREATININE; EZETIMIBE PLUS SIMVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; SIMVASTATIN; TRIACYLGLYCEROL; URIC ACID;

EID: 84871593533     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248412444463     Document Type: Article
Times cited : (12)

References (29)
  • 1
    • 33845781654 scopus 로고    scopus 로고
    • Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis
    • Coutinho Tde A, Turner ST, Peyser PA, Bielak LF, Sheedy PF, Kullo IJ. Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis. Am J Hypertens. 2007 ; 20 (1). 83-89
    • (2007) Am J Hypertens , vol.20 , Issue.1 , pp. 83-89
    • Coutinho Tde, A.1    Turner, S.T.2    Peyser, P.A.3    Bielak, L.F.4    Sheedy, P.F.5    Kullo, I.J.6
  • 2
    • 33748477254 scopus 로고    scopus 로고
    • Elevated serum uric acid levels in metabolic syndrome: An active component or an innocent bystander
    • Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander. Metabolism. 2006 ; 55 (10). 1293-1301
    • (2006) Metabolism , vol.55 , Issue.10 , pp. 1293-1301
    • Tsouli, S.G.1    Liberopoulos, E.N.2    Mikhailidis, D.P.3    Athyros, V.G.4    Elisaf, M.S.5
  • 3
    • 0034898396 scopus 로고    scopus 로고
    • Effect of atorvastatin on serum uric acid levels
    • Kakafika A, Tsimihodimos V, Elisaf M. Effect of atorvastatin on serum uric acid levels. Atherosclerosis. 2001 ; 158 (1). 255
    • (2001) Atherosclerosis , vol.158 , Issue.1 , pp. 255
    • Kakafika, A.1    Tsimihodimos, V.2    Elisaf, M.3
  • 4
    • 5344244028 scopus 로고    scopus 로고
    • Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia
    • Milionis HJ, Kakafika AI, Tsouli SG, et al. Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. Am Heart J. 2004 ; 148 (4). 635-640
    • (2004) Am Heart J , vol.148 , Issue.4 , pp. 635-640
    • Milionis, H.J.1    Kakafika, A.I.2    Tsouli, S.G.3
  • 5
    • 0038637275 scopus 로고    scopus 로고
    • Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia
    • Milionis HJ, Papakostas J, Kakafika A, Chasiotis G, Seferiadis K, Elisaf MS. Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia. J Clin Pharmacol. 2003 ; 43 (8). 825-830
    • (2003) J Clin Pharmacol , vol.43 , Issue.8 , pp. 825-830
    • Milionis, H.J.1    Papakostas, J.2    Kakafika, A.3    Chasiotis, G.4    Seferiadis, K.5    Elisaf, M.S.6
  • 6
    • 1542268611 scopus 로고    scopus 로고
    • Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: A subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study
    • Athyros VG, Elisaf M, Papageorgiou AA, et al. Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart- disease Evaluation (GREACE) study. Am J Kidney Dis. 2004 ; 43 (4). 589-599
    • (2004) Am J Kidney Dis , vol.43 , Issue.4 , pp. 589-599
    • Athyros, V.G.1    Elisaf, M.2    Papageorgiou, A.A.3
  • 7
    • 33846023704 scopus 로고    scopus 로고
    • Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study
    • Athyros VG, Mikhailidis DP, Liberopoulos EN, et al. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transplant. 2007 ; 22 (1). 118-127
    • (2007) Nephrol Dial Transplant , vol.22 , Issue.1 , pp. 118-127
    • Athyros, V.G.1    Mikhailidis, D.P.2    Liberopoulos, E.N.3
  • 8
    • 77953702031 scopus 로고    scopus 로고
    • Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients
    • Ogata N, Fujimori S, Oka Y, Kaneko K. Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients. Nucleosides Nucleotides Nucleic Acids. 2010 ; 29 (4-6). 321-324
    • (2010) Nucleosides Nucleotides Nucleic Acids , vol.29 , Issue.46 , pp. 321-324
    • Ogata, N.1    Fujimori, S.2    Oka, Y.3    Kaneko, K.4
  • 9
    • 0347093525 scopus 로고    scopus 로고
    • The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease
    • Youssef F, Gupta P, Seifalian AM, Myint F, Mikhailidis DP, Hamilton G. The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease. Angiology. 2004 ; 55 (1). 53-62
    • (2004) Angiology , vol.55 , Issue.1 , pp. 53-62
    • Youssef, F.1    Gupta, P.2    Seifalian, A.M.3    Myint, F.4    Mikhailidis, D.P.5    Hamilton, G.6
  • 10
    • 47949116865 scopus 로고    scopus 로고
    • The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia
    • Nakou ES, Filippatos TD, Georgoula M, et al. The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia. Curr Med Res Opin. 2008 ; 24 (7). 1919-1929
    • (2008) Curr Med Res Opin , vol.24 , Issue.7 , pp. 1919-1929
    • Nakou, E.S.1    Filippatos, T.D.2    Georgoula, M.3
  • 11
    • 36048987346 scopus 로고    scopus 로고
    • Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin
    • Gazi IF, Daskalopoulou SS, Nair DR, Mikhailidis DP. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin. Curr Med Res Opin. 2007 ; 23 (9). 2183-2192
    • (2007) Curr Med Res Opin , vol.23 , Issue.9 , pp. 2183-2192
    • Gazi, I.F.1    Daskalopoulou, S.S.2    Nair, D.R.3    Mikhailidis, D.P.4
  • 12
    • 80054712207 scopus 로고    scopus 로고
    • Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance
    • Moutzouri E, Liberopoulos E, Mikhailidis DP, et al. Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistance. Int J Clin Pract. 2011 ; 65 (11). 1141-1148
    • (2011) Int J Clin Pract , vol.65 , Issue.11 , pp. 1141-1148
    • Moutzouri, E.1    Liberopoulos, E.2    Mikhailidis, D.P.3
  • 13
    • 71749118226 scopus 로고    scopus 로고
    • Circulation. 2002: 3143-3421.
    • (2002) Circulation , pp. 3143-3421
  • 14
    • 10744221128 scopus 로고    scopus 로고
    • The impact of serum uric acid on cardiovascular outcomes in the LIFE study
    • Hoieggen A, Alderman MH, Kjeldsen SE, et al. The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int. 2004 ; 65 (3). 1041-1049
    • (2004) Kidney Int , vol.65 , Issue.3 , pp. 1041-1049
    • Hoieggen, A.1    Alderman, M.H.2    Kjeldsen, S.E.3
  • 15
    • 78649709694 scopus 로고    scopus 로고
    • Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study)
    • Brodov Y, Behar S, Boyko V, Chouraqui P. Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study). Am J Cardiol. 2010 ; 106 (12). 1717-1720
    • (2010) Am J Cardiol , vol.106 , Issue.12 , pp. 1717-1720
    • Brodov, Y.1    Behar, S.2    Boyko, V.3    Chouraqui, P.4
  • 16
    • 77950883722 scopus 로고    scopus 로고
    • Hypouricemic effect of statins: Another pleiotropic benefit?
    • Lopez-Cuenca A, Roldan V, Marin F. Hypouricemic effect of statins: another pleiotropic benefit?. J Thorac Cardiovasc Surg. 2010 ; 139 (5). 1358-1359
    • (2010) J Thorac Cardiovasc Surg , vol.139 , Issue.5 , pp. 1358-1359
    • Lopez-Cuenca, A.1    Roldan, V.2    Marin, F.3
  • 17
    • 79957778475 scopus 로고    scopus 로고
    • Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): The PATROL trial
    • Saku K, Zhang B, Noda K. Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial. Circ J. 2011 ; 75 (6). 1493-1505
    • (2011) Circ J , vol.75 , Issue.6 , pp. 1493-1505
    • Saku, K.1    Zhang, B.2    Noda, K.3
  • 18
    • 79960430739 scopus 로고    scopus 로고
    • Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study
    • Athyros VG, Karagiannis A, Ganotakis ES, et al. Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study. Curr Med Res Opin. 2011 ; 27 (8). 1659-1668
    • (2011) Curr Med Res Opin , vol.27 , Issue.8 , pp. 1659-1668
    • Athyros, V.G.1    Karagiannis, A.2    Ganotakis, E.S.3
  • 19
    • 33745714077 scopus 로고    scopus 로고
    • Treating to target patients with primary hyperlipidaemia: Comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study)
    • Milionis HJ, Rizos E, Kostapanos M, et al. Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study). Curr Med Res Opin. 2006 ; 22 (6). 1123-1131
    • (2006) Curr Med Res Opin , vol.22 , Issue.6 , pp. 1123-1131
    • Milionis, H.J.1    Rizos, E.2    Kostapanos, M.3
  • 20
    • 23744441488 scopus 로고    scopus 로고
    • Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome
    • Yoo TW, Sung KC, Shin HS, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J. 2005 ; 69 (8). 928-933
    • (2005) Circ J , vol.69 , Issue.8 , pp. 928-933
    • Yoo, T.W.1    Sung, K.C.2    Shin, H.S.3
  • 22
    • 80052647784 scopus 로고    scopus 로고
    • Do HMG-CoA reductase inhibitors improve kidney function the saga continues
    • Campese VM, Ku E, Bigazzi R, Bianchi S. Do HMG-CoA reductase inhibitors improve kidney function The saga continues. J Nephrol. 2011 ; 24 (5). 550-553
    • (2011) J Nephrol , vol.24 , Issue.5 , pp. 550-553
    • Campese, V.M.1    Ku, E.2    Bigazzi, R.3    Bianchi, S.4
  • 23
    • 38449119409 scopus 로고    scopus 로고
    • Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The Treating to New Targets (TNT) study
    • Shepherd J, Kastelein JJ, Bittner V, et al. Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. Clin J Am Soc Nephrol. 2007 ; 2 (6). 1131-1139
    • (2007) Clin J Am Soc Nephrol , vol.2 , Issue.6 , pp. 1131-1139
    • Shepherd, J.1    Kastelein, J.J.2    Bittner, V.3
  • 24
    • 77949332406 scopus 로고    scopus 로고
    • Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: A secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial
    • Ridker PM, MacFadyen J, Cressman M, Glynn RJ. Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. J Am Coll Cardiol. 2010 ; 55 (12). 1266-1273
    • (2010) J Am Coll Cardiol , vol.55 , Issue.12 , pp. 1266-1273
    • Ridker, P.M.1    MacFadyen, J.2    Cressman, M.3    Glynn, R.J.4
  • 25
    • 33749866051 scopus 로고    scopus 로고
    • Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemia
    • Kostapanos MS, Milionis HJ, Gazi I, Kostara C, Bairaktari ET, Elisaf M. Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemia. J Clin Pharmacol. 2006 ; 46 (11). 1337-1343
    • (2006) J Clin Pharmacol , vol.46 , Issue.11 , pp. 1337-1343
    • Kostapanos, M.S.1    Milionis, H.J.2    Gazi, I.3    Kostara, C.4    Bairaktari, E.T.5    Elisaf, M.6
  • 26
    • 43049116177 scopus 로고    scopus 로고
    • The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans
    • Ky B, Burke A, Tsimikas S, et al. The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans. J Am Coll Cardiol. 2008 ; 51 (17). 1653-1662
    • (2008) J Am Coll Cardiol , vol.51 , Issue.17 , pp. 1653-1662
    • Ky, B.1    Burke, A.2    Tsimikas, S.3
  • 27
    • 70349331942 scopus 로고    scopus 로고
    • Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner
    • Nakamura T, Sato E, Fujiwara N, et al. Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner. Pharmacol Res. 2009 ; 60 (6). 525-528
    • (2009) Pharmacol Res , vol.60 , Issue.6 , pp. 525-528
    • Nakamura, T.1    Sato, E.2    Fujiwara, N.3
  • 28
    • 44449096625 scopus 로고    scopus 로고
    • Ezetimibe treatment in hypercholesterolemic kidney transplant patients is safe and effective and reduces the decline of renal allograft function: A pilot study
    • Turk TR, Voropaeva E, Kohnle M, et al. Ezetimibe treatment in hypercholesterolemic kidney transplant patients is safe and effective and reduces the decline of renal allograft function: a pilot study. Nephrol Dial Transplant. 2008 ; 23 (1). 369-373
    • (2008) Nephrol Dial Transplant , vol.23 , Issue.1 , pp. 369-373
    • Turk, T.R.1    Voropaeva, E.2    Kohnle, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.